Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
‘Extraordinary’ Iron Age war trumpet uncovered in England - 2Senegal limits foreign trips for officials as the fallout from Iran war deepens
- 3Mom warns of Christmas gift hazard as daughter recovers in hospital
- 4Israeli Chief of Staff declares new border with Gaza Strip
- 5Finding Your Motivation: Moves toward a Satisfying Life
- China and Pakistan issue five-point peace plan for Middle East
- Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- America's Confided in Cooler in 2024
- Police break up illegal chicken slaughter in Germany
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
- Instructions to Explore the Therapy Choices for Cellular breakdown in the lungs
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Germany's Pistorius: NATO protects Europe from Iranian missiles
